vimarsana.com

Page 7 - Proprietary Laboratory Analyses News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunovia AB: Immunovia CPT PLA Code submission for the IMMray PanCan-d test is on the agenda of American Medical Association

Small Cap Wrap - Verici Dx, Tasty, Somero Enterprises and more

AMA Updates CPT Codes for COVID-19 Vaccines, Boosters

AMA Updates CPT Codes for COVID-19 Vaccines, Boosters
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker Assays

Press release content from PR Newswire. The AP news staff was not involved in its creation. Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker Assays April 27, 2021 GMT Eurofins Transplant Diagnostics LEE’S SUMMIT, Mo. and FRAMINGHAM, Mass., April 27, 2021 /PRNewswire/ Eurofins Viracor, one of the largest and most recognized infectious diseases testing laboratories in the United States, and Transplant Genomics, the trusted global partner in precision biomarkers for the transplant community innovating to improve patient outcomes, announce that the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) has approved the Viracor TRAC™ (Transplant Allograft Rejection Check) donor-derived cell-free DNA test and TruGraf® blood gene expression test, both of which help healthcare providers assess rejection status in kidney transplant recipients.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.